U.S. market Closed. Opens in 1 day 4 hours

HILS | Hillstream BioPharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/A
Operating Expenses9.46M6.88M3.21M1.52M994.54K
Selling, General & Admin5.90M4.60M1.37M671.88K625.81K
Research & Development3.56M2.28M1.84M847.27K368.73K
Other Operating ExpensesN/AN/A1.83M-362.49K-26.46K
Operating Income-9.46M-6.88M-3.21M-1.81M-1.42M
Other Expenses / Income136.13K-1.59M1.00M-609.02K-101.53K
Before Tax Income-9.32M-8.47M-2.21M-2.42M-1.53M
Income Tax ExpensesN/AN/A831.28K-42.67K-354.33K
Net Income-9.32M-8.47M-3.04M-2.37M-1.17M
Interest Expenses-16.50K1.59M831.28K246.53K75.07K
Basic Shares Outstanding1.31M11.23M10.30M11.23M11.23M
Diluted Shares Outstanding1.31M11.23M10.30M11.23M11.23M
EBITDA-9.46M-6.88M-1.38M-1.88M-1.02M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-9.34M-6.88M-1.38M-2.17M-1.45M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙